Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Warner-Lambert claims NK3 antagonists with broad therapeutic applications

Nov. 8, 1996

Favorable results reported for Targeted Genetics' CF gene therapy

Nov. 1, 1996

UCSF scientists discover new gene therapy approach to CF

Nov. 1, 1996

R-Albuterol for pediatric asthma

Nov. 1, 1996

Nonpeptide NK1/NK2 antagonist identified by Merck & Co.

Nov. 1, 1996

NK1/NK2 antagonist research at Hoechst Marion Roussel

Nov. 1, 1996

New antiallergic agents from Takeda

Nov. 1, 1996

Dual H1/NK1 antagonists as potential antiallergics

Nov. 1, 1996

GV-1101 available for licensing

Oct. 25, 1996

Gelsolin enters clinical trials

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...